RELATED CONTENT
NEWS
- BMS fronts up $24M for Ambrx 'biobetters' in heart failure and type 2 diabetes
- Anaphore acquires Chinese business and picks up final Series A tranche
- Telaprevir and fingolimod approved in Japan as ministry confirms recommendations
- Mitsubishi Tanabe taps Synageva for orphan drug R&D
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

